Search

everythinglearnresearchcommunity

for

Search:↓

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

A rare pancreatic tumor caused a woman's male-like features, treated successfully with surgery and medication.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

Tracnil™, a mix of myo-inositol, folic acid, and vitamin D3, safely reduced acne, improved excessive hair growth, and fixed irregular periods in overweight women with PCOS.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

A woman's rare adrenal tumor caused high testosterone and cortisol levels, which normalized after the tumor was removed.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The cat had liver cancer and a related hair loss condition, with a likely cause being bile duct cancer.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

A PET-CT scan successfully located a hard-to-find Leydig cell tumor in a woman with hormonal symptoms.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Androgen receptors play a key role in male development and prostate cancer, with treatments targeting androgen action.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Cetuximab can cause unusual hair growth and hair loss.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

Thorough evaluations and conservative management can lead to positive outcomes in pediatric adrenocortical carcinoma.